ETN vs URGN · P/E 39, rev $15.98B vs rev $109.8M
Eaton Corporation PLC (ETN) versus UroGen Pharma Ltd (URGN) — a side-by-side from cached financials, not a winner call.
Eaton Corporation PLC (ETN) is a specialty industrial machinery company listed on US.
UroGen Pharma Ltd (URGN) is a biotechnology company listed on NASDAQ.
Latest reported ETN revenue for 2026-06-30 was $15.98B. Net income was $1.69B. ETN currently screens at market cap $153.74B and trailing P/E 38.7.
Latest reported URGN revenue for 2025-12-31 was $109.8M. Net income was -$153.5M. URGN currently screens at market cap $1.61B.
ETN currently screens at market cap $153.74B and trailing P/E 38.7. URGN currently screens at market cap $1.61B.
Not investment advice. Open the ETN and URGN stock pages for the full models.
Not investment advice.